Analysis of RNA-seq data from the CCLE database revealed that FOXP1 expression levels (log2 TPM + 1) were relatively elevated in hematologic malignancy-derived cell lines, particularly those corresponding to DLBCL, AML, and acute lymphoblastic leukemia (ALL), compared to cell lines from other tumor types (Figure 1A). The gene discussed is FOXP1; the disease is acute lymphoblastic leukemia.